Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
43.59
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
29,293
Open
43.59
Bid (Size)
43.50 (1)
Ask (Size)
43.54 (1)
Prev. Close
43.59
Today's Range
43.59 - 43.59
52wk Range
41.45 - 56.32
Shares Outstanding
5,606,688,356
Dividend Yield
3.58%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Active Pharmaceutical Ingredients Market May Set Epic Growth Story : Pfizer, Novartis, Sanofi
February 07, 2023
Stay up-to-date with Active Pharmaceutical Ingredients Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Topics
Death
Exposures
Death
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023
February 07, 2023
Via
Benzinga
Performance
YTD
-14.96%
-14.96%
1 Month
-9.92%
-9.92%
3 Month
-7.94%
-7.94%
6 Month
-12.43%
-12.43%
1 Year
-18.08%
-18.08%
More News
Read More
This Healthcare Giant Expects Revenue to Crash More Than 30% This Year
February 07, 2023
Via
The Motley Fool
Pfizer's Sales Could Sink 33% in 2023. Here's Why to Buy the Stock Anyway.
February 02, 2023
Via
The Motley Fool
Pfizer (PFE) Q4 2022 Earnings Call Transcript
January 31, 2023
Via
The Motley Fool
3 Bargain Stocks to Snap Up Before the Crowd Gets Wise
February 06, 2023
Via
InvestorPlace
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
Via
Talk Markets
5 Stocks That Moved the Market in January
February 06, 2023
Via
The Motley Fool
The 3 Most Undervalued Growth Stocks for Your February Buy List
February 06, 2023
Via
InvestorPlace
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Via
The Motley Fool
Five Best And Worst Performing Healthcare Stocks In January 2023
February 05, 2023
Via
Talk Markets
Barron's Top Weekend Stock Picks: Apple, Disney, Pfizer And Tesla's Price Cuts Are Leading To Growth
February 04, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Rally
February 03, 2023
Via
Benzinga
Biosimilars Market 2023 Industry Size, Share, Growth and Analysis by Demand, Opportunity, Key Players, Regional Development and Forecast 2029
February 03, 2023
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?
February 03, 2023
Via
The Motley Fool
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
February 02, 2023
Via
MarketBeat
Topics
ETFs
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
February 02, 2023
Via
Investor's Business Daily
Got $1,000? 3 Cheap Stocks To Buy Right Now
February 02, 2023
Via
The Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
Via
The Motley Fool
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Via
MarketBeat
Exposures
COVID-19
Product Safety
AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday
February 01, 2023
Via
Benzinga
Pfizer Stock: What the Bulls and Bears are Getting Wrong
February 01, 2023
Via
MarketBeat
S&P 500 Jumps 1.5%, Market Volatility Decreases
February 01, 2023
Via
Benzinga
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Via
The Motley Fool
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast
January 31, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.